Newsfeeds - Spark Newswire

3 minute read

28 Stocks Moving in Friday’s Pre-Market Session

Today, 6:55 AM

Gainers Sphere 3D Corp. (NASDAQ: ANY) shares rose 35.4% to $4.66 in pre-market trading after the company reported an Agreement to acquire exclusive rights for assignment of cryptocurrency mining assets.

ABUS

3 minute read

A Peek Into The Markets: US Stock Futures Mostly Flat; All Eyes On Jobs Report

By Lisa Levin

Today, 6:55 AM

Pre-open movers

AAPL

1 minute read

5 Stocks To Watch For August 6, 2021

By Lisa Levin

Today, 6:55 AM

Some of the stocks that may grab investor focus today are: Wall Street expects Lear Corporation (NYSE: LEA) to report quarterly earnings at $2.68 per share on revenue of $4.91 billion before the opening bell. Lear shares fell 0.3% to $168.84 in after-hours trading.

DBX

1 minute read

Here’s Why Novavax Stock Is Crashing

By Shivdeep Dhaliwal

Today, 6:55 AM

Novavax, Inc (NASDAQ: NVAX) shares slipped nearly 10% in the after-hours trading on Thursday. What’s Moving? The biotechnology company’s shares crashed 9.79% to $213.07 in the after-hours session on Thursday after closing 5.54% higher at $236.20.

NVAX

1 minute read

Earnings

Recap: Novavax Q2 Earnings

By Benzinga Insights

Today, 6:55 AM

Shares of Novavax (NASDAQ:NVAX) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 1483.33% year over year to ($4.75), which missed the estimate of ($3.63).

NVAX

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

Today, 6:55 AM

Gainers

ENDP

1 minute read

FDA Is Developing A COVID-19 Vaccine Booster Plan, Could Be Ready ‘Within Weeks,’ ‘By September’

By Benzinga Newsdesk

Today, 6:55 AM

-Dow Jones

BNTX

1 minute read

Novavax Q2 EPS $(4.75) Misses $(3.63) Estimate, Sales $298.02M

By Benzinga Newsdesk

Today, 6:55 AM

Novavax (NASDAQ:NVAX) reported quarterly losses of $(4.75) per share which missed the analyst consensus estimate of $(3.63) by 30.85 percent. This is a 1483.33 percent decrease over losses of $(0.30) per share from the

NVAX

2 minute read

FDA
News

Novavax Announces COVID-19 Vaccine Booster Data Demonstrating 4-Fold Increase In Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination

By Benzinga Newsdesk

Today, 6:55 AM

Novavax, Inc. (NASDAQ:NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced preliminary data demonstrating that a single booster dose of its recombinant

NVAX

1 minute read

Why Novavax Shares Are Trading Higher Today

By Henry Khederian

Today, 6:55 AM

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 8.4% at $242.67 on continued strength after the company on Wednesday announced an agreement with the European Commission for the purchase of up to 200 million doses of its COVID-19 vaccine.

NVAX